u/Bailey-96 · 244d agono track record yet
IBRX (ImmunityBio) - Great squeeze potential
IBRX is poised for a short squeeze with ~40% short interest, only 10 days to cover, and a pipeline of positive catalysts (lung cancer data, Saudi FDA approval, glioblastoma and CAR-NK data). The company has strong fundamentals (424% YoY revenue growth, $257M cash) that support a breakout above $3.00.
At post $6.21Now $8.14+31.1% since postedas of Sep 15, 4:30 PM ET